A novel strategy for the management of cytomegalovirus retinitis in immunocompromised patients using new anti-cytomegalovirus drugs. (PubMed, Front Med (Lausanne)) - Jun 26, 2025 - "Weekly intravitreal injections of high-dose (6 mg) ganciclovir (IVG) were administered to those with macula involvement or aggressive lesions during the initial treatment. Both letermovir and maribavir demonstrated excellent tolerability with no adverse events observed. This novel therapeutic strategy provides safe and effective treatment option for CMVR, particularly promising for patients with complex systemic comorbidities."
Journal • Cytomegalovirus Infection • Genetic Disorders • Ocular Inflammation • Ophthalmology • Retinal Disorders
|
|
Enzhong Jin; Heng Miao; Jing Hou; Jiyang Tang; Qiaozhu Zeng; Yaoyao Sun; Yi Cai; Yuou Yao
|